Cells talk to each other by releasing packages. Exosomes are among the smallest of them — vesicles roughly 30 to 150 nanometres across, carrying proteins, lipids and RNA from the cell that made them to whichever cell takes them up. The receiving cell reads the contents and changes its behaviour accordingly.
That is the entire premise of exosome mesotherapy. Rather than placing new cells in your skin, you deliver the instructions cells use to coordinate repair, and let the fibroblasts already there act on them.
Why they are paired with microneedling
An exosome is far too large to cross intact skin. Left on the surface, most of it stays on the surface.
This is why exosome treatment is almost always performed immediately after microneedling or a fractional laser. The device creates thousands of temporary channels through the epidermis, and the vesicles are applied while those channels are still open. The pairing is not marketing — it is the delivery mechanism, and it is also why the treatment carries the downtime of the device rather than of the exosomes.
It also means you are receiving two interventions at once. Microneedling on its own stimulates collagen. Any assessment of what the exosomes contributed has to account for what the needles would have done anyway, which is exactly why the study design below matters.
What the controlled studies report
The most informative work uses a split-face design: microneedling on the whole face, exosomes applied to one side only, the same patient as their own control. It removes most of the variables that make cosmetic studies hard to read.
Those studies generally favour the exosome side, with greater improvement in texture, hydration, elasticity and pigmentation. Investigators using the Global Aesthetic Improvement Scale have reported scores in the “much improved” to “very much improved” range, with satisfaction holding at follow-up several months out.
Reviewing the wider literature, seventeen studies published between 2020 and 2025 covered skin ageing, melasma and hyperpigmentation, enlarged pores, active acne, atrophic scarring and androgenetic alopecia. Around three quarters recorded improvement in at least one measured outcome.
Read that as encouraging and preliminary at the same time. These are small studies, often without blinding, with short follow-up and — the largest problem — no standardised product. Two clinics can both offer “exosome therapy” using preparations that differ in source tissue, particle count, purity and handling. A systematic review published in 2026 in the Journal of Cosmetic Dermatology found early evidence of efficacy across several indications and called explicitly for larger and longer trials to confirm it.
The regulatory position, stated plainly
The US FDA safety alert states that there are no FDA-approved exosome products and describes approval requirements for products intended to treat disease. This statement concerns the United States; it does not establish the status of a product in Thailand.
Before treatment in Thailand, ask the clinic for the exact product name, manufacturer, proposed route and documentation of its local status. Do not assume that a product intended for intact skin is authorized for application after microneedling or for injection.
Product registration and clinical evidence answer different questions. Ask what evidence supports the specific use being proposed, what risks are known and how the clinic will manage an adverse reaction.
What to ask before booking
- Where is the product sourced, and can I see the documentation? Source tissue, manufacturer and batch information should exist and should be available to you.
- How is it stored? Exosome preparations are temperature-sensitive. Cold chain is a real question, not a formality.
- What is being done alongside it? Microneedling, fractional laser and radiofrequency have different recovery profiles and different suitability depending on your skin type.
- What outcome are we tracking, and how? Standardised photography under fixed lighting at a defined interval. “You’ll see” is not a measurement.
- What would make you advise against this for me? Active acne infection, recent isotretinoin use, a keloid tendency and certain pigmentation disorders all change the calculation.
Where it fits
Exosome work sits alongside other regenerative options rather than replacing them, and it is not the right answer for every skin concern. Deep static lines and significant laxity respond to different tools. Texture, tone, pore appearance and post-inflammatory pigmentation are where the reported results cluster.
At ARPAR the assessment comes before the recommendation, and where the evidence is early we say so — as we have here. If you want to know what would actually help your skin, that conversation starts with someone looking at it.